Get the Stockscreener App
14.73
2.79%
0.40
After Hours:
14.70
-0.03
-0.20%
Medifast Inc stock is traded at $14.73, with a volume of 328.00K.
It is up +2.79% in the last 24 hours and down -6.42% over the past month.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
See More
Previous Close:
$14.33
Open:
$14.52
24h Volume:
328.00K
Relative Volume:
1.41
Market Cap:
$161.11M
Revenue:
$1.07B
Net Income/Loss:
$99.41M
P/E Ratio:
1.6258
EPS:
9.06
Net Cash Flow:
$141.17M
1W Performance:
-9.13%
1M Performance:
-6.42%
6M Performance:
-24.27%
1Y Performance:
-63.52%
1-Day Range:
$14.24
$14.94
1-Week Range:
$13.57
$16.45
52-Week Range:
$13.57
$42.68
Medifast Inc Stock (MED) Company Profile
Name
Medifast Inc
Sector
Industry
Phone
(732) 764-0619
Address
11445 CRONHILL DRIVE, OWINGS MILLS, MD
Compare MED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MED
Medifast Inc
|
14.73 | 161.11M | 1.07B | 99.41M | 141.17M | 9.06 |
|
ROL
Rollins Inc
|
51.29 | 24.84B | 3.31B | 469.51M | 537.75M | 0.96 |
|
SCI
Service Corp International
|
78.91 | 11.38B | 4.15B | 505.69M | 587.50M | 3.44 |
|
BFAM
Bright Horizons Family Solutions Inc
|
126.39 | 7.35B | 2.63B | 116.59M | 215.93M | 1.99 |
|
HRB
H R Block Inc
|
52.27 | 7.00B | 3.62B | 586.22M | 657.77M | 4.10 |
|
FTDR
Frontdoor Inc
|
57.10 | 4.33B | 1.83B | 234.00M | 235.00M | 3.03 |
Medifast Inc Stock (MED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Upgrade | DA Davidson | Underperform → Neutral |
| Jun-05-24 | Downgrade | DA Davidson | Neutral → Underperform |
| Oct-13-23 | Initiated | Stephens | Equal-Weight |
| Nov-04-22 | Downgrade | DA Davidson | Buy → Neutral |
| Aug-04-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-25-21 | Upgrade | Jefferies | Hold → Buy |
| Nov-05-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jun-25-20 | Initiated | B. Riley FBR | Buy |
| Feb-27-20 | Downgrade | Jefferies | Buy → Hold |
| Nov-08-19 | Downgrade | Dougherty & Company | Buy → Neutral |
| Jul-25-19 | Initiated | Jefferies | Buy |
| Nov-08-18 | Upgrade | Sidoti | Neutral → Buy |
| Mar-07-18 | Upgrade | Sidoti | Neutral → Buy |
| Sep-15-17 | Reiterated | DA Davidson | Buy |
| Aug-04-16 | Reiterated | Wunderlich | Hold |
| Jan-11-16 | Upgrade | Sidoti | Neutral → Buy |
| Nov-30-15 | Downgrade | Sidoti | Buy → Neutral |
| Oct-05-15 | Upgrade | Sidoti | Neutral → Buy |
| Nov-07-14 | Downgrade | Imperial Capital | Outperform → In-line |
| Aug-08-14 | Reiterated | Imperial Capital | Outperform |
| Apr-23-14 | Reiterated | Imperial Capital | Outperform |
| Sep-06-13 | Initiated | Imperial Capital | Outperform |
| Nov-06-12 | Reiterated | Northland Securities | Outperform |
| Jul-27-12 | Upgrade | Northland Securities | Market Perform → Outperform |
| Jul-09-12 | Downgrade | Standpoint Research | Buy → Hold |
| Jan-30-12 | Initiated | Standpoint Research | Buy |
View All
Medifast Inc Stock (MED) Latest News
Institutional owners may take dramatic actions as Medifast, Inc.'s (NYSE:MED) recent 11% drop adds to one-year losses - Simply Wall St
MED Q4 Earnings Beat, Revenues Dip Y/Y on Lower Customer Acquisition - MSN
Medifast stock target cut to $16.50 by DA Davidson - Investing.com UK
Medifast (MED) PT Lowered to $16.50 at DA Davidson - StreetInsider.com
Medifast Reports Financial Results for Q4 and Full Year 2024 - Direct Selling News
Medifast stock hits 52-week low at $14.76 amid sharp decline - Investing.com
Medifast, Inc. (NYSE:MED) Q4 2024 Earnings Call Transcript - MSN
Medifast Beats Revenue Expectations Amidst Sharp Sales DeclineNews and Statistics - IndexBox, Inc.
Medifast: Q4 Earnings Snapshot - mySA
Medifast Inc (MED) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire
Medifast outlines 2025 priorities with plans for $15M-$20M cost savings and new product expansions - MSN
Medifast (MED) Q4 Earnings Report Preview: What To Look For - MSN
Earnings call transcript: Medifast Q4 2024 beats EPS, misses revenue - Investing.com
Medifast (MED) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
Medifast Inc reports results for the quarter ended December 31Earnings Summary - TradingView
MEDIFAST INC SEC 10-K Report - TradingView
Medifast (NYSE:MED) Surprises With Q4 Sales But Quarterly Revenue Guidance Significantly Misses Expectations - Investing.com Canada
Medifast Q4 Earnings Reveal Sharp Revenue Drop Despite $162M Cash Cushion - StockTitan
Medifast stock hits 52-week low at $14.88 amid sharp decline - Investing.com Nigeria
Medifast (MED) Q4 Earnings Report Preview: What To Look For By Stock Story - Investing.com Canada
What Is Medifast, Inc.'s (NYSE:MED) Share Price Doing? - Yahoo Finance
Medifast (MED) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Medifast, Inc. (MED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Medifast stock hits 52-week low at $14.88 amid sharp decline By Investing.com - Investing.com South Africa
Medifast, Inc. to Host Earnings Call - ACCESS Newswire
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Business Wire
Medifast Earnings Alert: Key Financial Results Coming February 18What's at Stake for OPTAVIA - StockTitan
JPMorgan Chase & Co. Increases Position in Medifast, Inc. (NYSE:MED) - MarketBeat
MED Focused on GLP-1 Solutions Amid Customer Acquisition Challenges - MSN
Medifast: Strong Balance Sheet, But I Lack Conviction In The Turnaround (NYSE:MED) - Seeking Alpha
Medifast stock hits 52-week low at $15.09 amid sharp decline - MSN
Weight Loss Diet Products Market Projected To Witness Substantial Growth, 2024-2031|VLCC Healthcare Ltd, - EIN News
Medifast Launches OPTAVIA ASCEND for Weight Loss Management - MSN
An Intrinsic Calculation For Medifast, Inc. (NYSE:MED) Suggests It's 41% Undervalued - Simply Wall St
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off - Marketscreener.com
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off – Company AnnouncementFT.com - Financial Times
Medifast Launches OPTAVIA ASCEND: High-Protein Line Targets GLP-1 Weight Management Challenge - StockTitan
Medifast stock hits 52-week low at $16.7 amid sharp decline - Investing.com Nigeria
Medifast, Inc. (NYSE:MED) Stock Holdings Decreased by Geode Capital Management LLC - MarketBeat
Medifast Inc Stock (MED) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.29%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):